Comparison of the CINP Clinical Guidelines with Other Previously Developed Guidelines for Acute Bipolar Depression
| . | CINP 2017 . | WFSBP 2013a . | CANMAT and ISBD 2013 . | NICE 2014 b . | BAP 2016b . |
|---|---|---|---|---|---|
| Lurasidone | 1 | - | 2 | - | 1 |
| OFC | 1 | 3 | 1 | 1 | 1 |
| Quetiapine | 1 | 1 | 1 | 1 | 1 |
| Valproate | 2 | 3 | 2 | 1 | - |
| Lithium | 2 | 5 | 1 | 1 | 3 |
| Escitalopram | 2 | - | 3 | ||
| Fluoxetine | 2 | 3 | - | - | 3 |
| Aripiprazole | 3 | - | NR | - | - |
| Imipramine | 3 | - | 4 | ||
| Phenelzine | 3 | - | - | ||
| Carbamazepine | 4 | 5 | 3 | - | - |
| Lamotrigine | 4 | 3 | 1 | 1 | 2 |
| Olanzapine | 4 | 3 | 3 | 1 | 1 |
| Tranylcypromine | 4 | - | - | - | 4 |
| ECT | 5 | 4 | 3 | - | 5 |
| Gabapentin | NR | - | NR | - | - |
| Leviracetam | - | - | NR | - | - |
| L-thyroxine | - | 4 | - | - | - |
| Paroxetine | NR | - | - | - | 3 |
| Risperidone | - | - | NR | - | - |
| rTMS | NR | - | - | - | - |
| Ziprasidone | NR | - | NR | - | - |
| . | CINP 2017 . | WFSBP 2013a . | CANMAT and ISBD 2013 . | NICE 2014 b . | BAP 2016b . |
|---|---|---|---|---|---|
| Lurasidone | 1 | - | 2 | - | 1 |
| OFC | 1 | 3 | 1 | 1 | 1 |
| Quetiapine | 1 | 1 | 1 | 1 | 1 |
| Valproate | 2 | 3 | 2 | 1 | - |
| Lithium | 2 | 5 | 1 | 1 | 3 |
| Escitalopram | 2 | - | 3 | ||
| Fluoxetine | 2 | 3 | - | - | 3 |
| Aripiprazole | 3 | - | NR | - | - |
| Imipramine | 3 | - | 4 | ||
| Phenelzine | 3 | - | - | ||
| Carbamazepine | 4 | 5 | 3 | - | - |
| Lamotrigine | 4 | 3 | 1 | 1 | 2 |
| Olanzapine | 4 | 3 | 3 | 1 | 1 |
| Tranylcypromine | 4 | - | - | - | 4 |
| ECT | 5 | 4 | 3 | - | 5 |
| Gabapentin | NR | - | NR | - | - |
| Leviracetam | - | - | NR | - | - |
| L-thyroxine | - | 4 | - | - | - |
| Paroxetine | NR | - | - | - | 3 |
| Risperidone | - | - | NR | - | - |
| rTMS | NR | - | - | - | - |
| Ziprasidone | NR | - | NR | - | - |
Abbreviations: ECT, electroconvulsive therapy; NR, not recommended; OFC, olanzapine-fluoxetine combination; rTMS, repetitive Transcranial Magnetic Stimulation.
The grading is not uniform; instead it reflects the grading utilized by individual guidelines and the table aims only to give an image of how different guidelines prioritize treatment options.
a WFSBP: Recommendation reflects only monotherapy not considering evidence derived from combination treatment (except OFC).
b NICE and BAP ordering is on the basis of line of treatment.
Comparison of the CINP Clinical Guidelines with Other Previously Developed Guidelines for Acute Bipolar Depression
| . | CINP 2017 . | WFSBP 2013a . | CANMAT and ISBD 2013 . | NICE 2014 b . | BAP 2016b . |
|---|---|---|---|---|---|
| Lurasidone | 1 | - | 2 | - | 1 |
| OFC | 1 | 3 | 1 | 1 | 1 |
| Quetiapine | 1 | 1 | 1 | 1 | 1 |
| Valproate | 2 | 3 | 2 | 1 | - |
| Lithium | 2 | 5 | 1 | 1 | 3 |
| Escitalopram | 2 | - | 3 | ||
| Fluoxetine | 2 | 3 | - | - | 3 |
| Aripiprazole | 3 | - | NR | - | - |
| Imipramine | 3 | - | 4 | ||
| Phenelzine | 3 | - | - | ||
| Carbamazepine | 4 | 5 | 3 | - | - |
| Lamotrigine | 4 | 3 | 1 | 1 | 2 |
| Olanzapine | 4 | 3 | 3 | 1 | 1 |
| Tranylcypromine | 4 | - | - | - | 4 |
| ECT | 5 | 4 | 3 | - | 5 |
| Gabapentin | NR | - | NR | - | - |
| Leviracetam | - | - | NR | - | - |
| L-thyroxine | - | 4 | - | - | - |
| Paroxetine | NR | - | - | - | 3 |
| Risperidone | - | - | NR | - | - |
| rTMS | NR | - | - | - | - |
| Ziprasidone | NR | - | NR | - | - |
| . | CINP 2017 . | WFSBP 2013a . | CANMAT and ISBD 2013 . | NICE 2014 b . | BAP 2016b . |
|---|---|---|---|---|---|
| Lurasidone | 1 | - | 2 | - | 1 |
| OFC | 1 | 3 | 1 | 1 | 1 |
| Quetiapine | 1 | 1 | 1 | 1 | 1 |
| Valproate | 2 | 3 | 2 | 1 | - |
| Lithium | 2 | 5 | 1 | 1 | 3 |
| Escitalopram | 2 | - | 3 | ||
| Fluoxetine | 2 | 3 | - | - | 3 |
| Aripiprazole | 3 | - | NR | - | - |
| Imipramine | 3 | - | 4 | ||
| Phenelzine | 3 | - | - | ||
| Carbamazepine | 4 | 5 | 3 | - | - |
| Lamotrigine | 4 | 3 | 1 | 1 | 2 |
| Olanzapine | 4 | 3 | 3 | 1 | 1 |
| Tranylcypromine | 4 | - | - | - | 4 |
| ECT | 5 | 4 | 3 | - | 5 |
| Gabapentin | NR | - | NR | - | - |
| Leviracetam | - | - | NR | - | - |
| L-thyroxine | - | 4 | - | - | - |
| Paroxetine | NR | - | - | - | 3 |
| Risperidone | - | - | NR | - | - |
| rTMS | NR | - | - | - | - |
| Ziprasidone | NR | - | NR | - | - |
Abbreviations: ECT, electroconvulsive therapy; NR, not recommended; OFC, olanzapine-fluoxetine combination; rTMS, repetitive Transcranial Magnetic Stimulation.
The grading is not uniform; instead it reflects the grading utilized by individual guidelines and the table aims only to give an image of how different guidelines prioritize treatment options.
a WFSBP: Recommendation reflects only monotherapy not considering evidence derived from combination treatment (except OFC).
b NICE and BAP ordering is on the basis of line of treatment.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
